RNPC3 and cancer: Fourthly, once inside the cancer cells, the CRISPR-Cas RNP complex precisely cuts and deactivates the oncogenes responsible for the malignancy, while the delivered cancer-killing molecules initiate apoptosis (cell death) or render the cancer cells susceptible to the body's immune response [47].